Search…

Hengrui Medicine (01276.HK) has received the Drug Clinical Trial Approval Notification Letter issued by the National Medical Products Administration regarding HRS-6093 tablets.

26/08/2025

Intelligence Financial APP News, Hengrui Medicine (01276.HK) announced that recently, the company received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration ("NMPA") for HRS-6093 tablets, and will conduct clinical trials in the near future.

Latest

3 m ago

After the French Prime Minister called for a vote of confidence, the yield on France's 10-year government bonds rose 9 basis points on the day, reaching the highest level since March.

3 m ago

The risk premium of French 10-year bonds compared to German bonds of the same maturity has increased by 6.6 basis points to 76.6 basis points, the widest level since April.

7 m ago

According to the US Energy Information Administration, the oil refinery of British Petroleum located in Whiting, Indiana, with a daily processing capacity of 440,000 barrels, is expected to fully resume operations within the next 24 to 48 hours.

7 m ago

According to the U.S. Energy Information Administration (IIR), British Petroleum (BP)'s refinery in Whiting, Indiana, with a daily processing capacity of 440,000 barrels, is expected to resume full operations within the next 24 to 48 hours.

14 m ago

Buffett: But I did meet with the CEO of CSX to discuss ways to strengthen our partnership.

See all latest